The CIRO Academy in Horn (the Netherlands) organised a 2-day meeting to present and discuss the studies published in 2017 pertaining to key priority areas of respiratory and critical care medicine. This review summarises studies focussing on pulmonary rehabilitation and exercise training, physical activity, chronic respiratory failure and palliative respiratory care published in 2017.
- pulmonary rehabilitation
- palliative care
- long-term oxygen therapy
Statistics from Altmetric.com
Contributors Drafting of specific parts of the text: MAS, CR, FP, KK, AMWJS, NH, EW, SN, MD, DJAJ, MJJ, JRC, MS and FMEF; planning and supervision of the work: MAS; critical revision of the text for important intellectual content: MAS, CR, FP, KK, AMWJS, NH, EW, SN, MD, DJAJ, MJJ, JRC, MS and FMEF. MAS is responsible for the overall content as guarantor. All authors approved the version published.
Funding CIRO’s International Year in Review 2017 was endorsed by the European Respiratory Society and financially supported by AstraZeneca, GSK, Novartis, TEVA, ResMed, CareFusion and the Netherlands Respiratory Society.
Competing interests JRC, MD, MJJ, KK, SN, FP, MS, CR, AMWJS and MAS have nothing to disclose. MD reports personal fees from Philips, ResMed, Weinmann, Heinen und Löwenstein, Fisher and grants from ResMed, outside the submitted work. FF reports personal fees from AstraZeneca, Chiesi, GlaxoSmithKline, Boehringer Ingelheim, Novartis and TEVA, outside the submitted work. NH is on the Pulmonary Research Advisory Board for Philips. NH’s research group has received unrestricted grants (managed by Guy’s) and Philips-Respironics is contributing to the development of the MYOTRACE technology. DJAJ reports personal fees from AstraZeneca, Novartis, Boehringer Ingelheim, GlaxoSmithKline and Mayne Pharma, outside the submitted work.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.